Page 176 - Programme book for The International Liver Congress 2015, EASL ILC 2015

Liver Tumours: Clinical (Epidemiology, Diagnosis)

P0325 EVERY 3-MONTH SURVEILLANCE IS SUPERIOR TO
SEMIANNUAL SURVEILLANCE FOR THE SURVIVAL OF
PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER
HEPATECTOMY: A 10-YEAR OBSERVATIONAL STUDY
Minjong Lee*, Sohee Oh,Young Youn Cho, Jeong-Ju Yoo,Yuri Cho,
Dong Hyeon Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu,
Nam-Joon Yi, Kwang-Woong Lee, Jung-Hwan Yoon, Kyung-Suk Suh,
Hyo-Suk Lee,Yoon Jun Kim, South Korea

P0326 HEPATOCELLULAR CARCINOMA (HCC) IN HCV-PATIENTS
WITH OR WITHOUT HIV-COINFECTION. SIMILAR
SURVIVAL IN A NATIONWIDE STUDY
Nathalie Goutté*, Philippe Sogni, Noëlle Bendersky, Bruno Falissard,
Olivier Farges, France

P0327 ANALYSIS OF HEPATIC PROGENITOR CELL MARKER
POSITIVE HEPATOCELLULAR CARCINOMA AND THEIR
ePOSTERS PROGNOSTIC SIGNIFICANCE
Atsunori Tsuchiya*,Yuichi Kojima, Satoshi Seino,Yusuke Watanabe,
Minoru Nomoto, Stuart J. Forbes, Shuji Terai, Japan

P0328 INCIDENCE, CHARACTERISTICS AND DETERMINANTS
OF PRIMARY LIVER CANCER OCCURRING DURING
SURVEILLANCE OF COMPENSATED HCV CIRRHOSIS
ACCORDING TO SUSTAINED VIROLOGICAL RESPONSE
(ANRS CO12 CIRVIR)
Pierre Nahon*, Valérie Bourcier, Richard Layese, Nabila Talmat,
Setty Allam, Patrick Marcellin, Dominique Guyader, Stanislas Pol,
Dominique Larrey, Fabien Zoulim, Dominique Roulot,
Victor de lédinghen, Denis Ouzan, Jean-Pierre Zarski,
Jean-Claude Trinchet, Françoise Roudot-Thoraval, France

P0329 THE ITA.LI.CA STAGING SYSTEM FOR PATIENTS WITH
HEPATOCELLULAR CARCINOMA: A MULTICENTER
COHORT STUDY
Fabio Farinati, Alessandro Vitale*, Franco Trevisani, Teh-La Huo,
Yun-Hsuan Lee, Umberto Cillo, Italy

176 The International Liver Congress™ 2015 • ILC Programme